Orchid signs deal with Biovitrum in drug discovery field

Orchid Chemicals & Pharmaceuticals Ltd on October 30, 2006 has announced that it has signed a contract with Biovitrum to undertake medicinal chemistry work to support certain drug discovery activities of Biovitrum AB (publ). Biovitrum is an integrated biopharma company with a broad project portfolio and operations in drug discovery research, development, manufacturing and product sales, headquartered in Sweden, Europe.

The Company considers this tie-up as yet another validation its ability to offer world-class drug discovery services to reputed clients around the globe.

Source : Equity Bulls

Keywords